These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32776697)

  • 21. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
    Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
    Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
    Guergueltcheva V; Müller JS; Dusl M; Senderek J; Oldfors A; Lindbergh C; Maxwell S; Colomer J; Mallebrera CJ; Nascimento A; Vilchez JJ; Muelas N; Kirschner J; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Schlotter B; Schoser B; Herrmann R; Voit T; Steinlein OK; Najafi A; Urtizberea A; Soler DM; Muntoni F; Hanna MG; Chaouch A; Straub V; Bushby K; Palace J; Beeson D; Abicht A; Lochmüller H
    J Neurol; 2012 May; 259(5):838-50. PubMed ID: 21975507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing the Understanding of Vesicle-Associated Membrane Protein 1-Related Congenital Myasthenic Syndrome: Phenotypic Insights, Favorable Response to 3,4-Diaminopyridine, and Clinical Characterization of Five New Cases.
    Natera-de Benito D; Pugliese A; Polavarapu K; Guergueltcheva V; Tournev I; Todorova A; Afonso Ribeiro J; Fernández-Mayoralas DM; Ortez C; Martorell L; Estévez-Arias B; Matalonga L; Laurie S; Jou C; Lau J; Thompson R; Shen X; Engel AG; Nascimento A; Lochmüller H; Selcen D
    Pediatr Neurol; 2024 Aug; 157():5-13. PubMed ID: 38833907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a new SYT2 variant validates an unusual distal motor neuropathy phenotype.
    Montes-Chinea NI; Guan Z; Coutts M; Vidal C; Courel S; Rebelo AP; Abreu L; Zuchner S; Littleton JT; Saporta MA
    Neurol Genet; 2018 Dec; 4(6):e282. PubMed ID: 30533528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization.
    Wang H; Salter CG; Refai O; Hardy H; Barwick KES; Akpulat U; Kvarnung M; Chioza BA; Harlalka G; Taylan F; Sejersen T; Wright J; Zimmerman HH; Karakaya M; Stüve B; Weis J; Schara U; Russell MA; Abdul-Rahman OA; Chilton J; Blakely RD; Baple EL; Cirak S; Crosby AH
    Brain; 2017 Nov; 140(11):2838-2850. PubMed ID: 29088354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Electrophysiology of Presynaptic Congenital Myasthenic Syndromes With and Without Facilitation: From Electrodiagnostic Findings to Molecular Mechanisms.
    Nicolau S; Milone M
    Front Neurol; 2019; 10():257. PubMed ID: 30941097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital myasthenic syndrome caused by novel COL13A1 mutations.
    Dusl M; Moreno T; Munell F; Macaya A; Gratacòs M; Abicht A; Strom TM; Lochmüller H; Senderek J
    J Neurol; 2019 May; 266(5):1107-1112. PubMed ID: 30767057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness.
    Owen D; Töpf A; Preethish-Kumar V; Lorenzoni PJ; Vroling B; Scola RH; Dias-Tosta E; Geraldo A; Polavarapu K; Nashi S; Cox D; Evangelista T; Dawson J; Thompson R; Senderek J; Laurie S; Beltran S; Gut M; Gut I; Nalini A; Lochmüller H
    Am J Med Genet A; 2018 Jul; 176(7):1594-1601. PubMed ID: 29704306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models.
    Pugliese A; Holland SH; Rodolico C; Lochmüller H; Spendiff S
    J Neuromuscul Dis; 2023; 10(5):731-759. PubMed ID: 37212067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment.
    McMacken G; Whittaker RG; Wake R; Lochmuller H; Horvath R
    J Neurol; 2023 Jun; 270(6):3112-3119. PubMed ID: 36869887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
    Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
    Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
    Abicht A; Stucka R; Karcagi V; Herczegfalvi A; Horváth R; Mortier W; Schara U; Ramaekers V; Jost W; Brunner J; Janssen G; Seidel U; Schlotter B; Müller-Felber W; Pongratz D; Rüdel R; Lochmüller H
    Neurology; 1999 Oct; 53(7):1564-9. PubMed ID: 10534268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COLQ-related congenital myasthenic syndrome: An integrative view.
    Eshaghian T; Rabbani B; Badv RS; Mikaeeli S; Gharib B; Iyadurai S; Mahdieh N
    Neurogenetics; 2023 Jul; 24(3):189-200. PubMed ID: 37231228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A spontaneous missense mutation in the chromodomain helicase DNA-binding protein 8 (CHD8) gene: a novel association with congenital myasthenic syndrome.
    Lee CY; Petkova M; Morales-Gonzalez S; Gimber N; Schmoranzer J; Meisel A; Böhmerle W; Stenzel W; Schuelke M; Schwarz JM
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):588-601. PubMed ID: 32267004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital myasthenic syndromes.
    Eymard B; Hantaï D; Estournet B
    Handb Clin Neurol; 2013; 113():1469-80. PubMed ID: 23622369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and genetic basis of congenital myasthenic syndromes.
    Souza PV; Batistella GN; Lino VC; Pinto WB; Annes M; Oliveira AS
    Arq Neuropsiquiatr; 2016 Sep; 74(9):750-760. PubMed ID: 27706425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
    Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
    Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - A recognizable clinical phenotype.
    Polavarapu K; Vengalil S; Preethish-Kumar V; Arunachal G; Nashi S; Mohan D; Chawla T; Bardhan M; Nandeesh B; Gupta P; Gowda VK; Lochmüller H; Nalini A
    Eur J Paediatr Neurol; 2021 Mar; 31():54-60. PubMed ID: 33631708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.